{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:58:40Z","timestamp":1790740720791,"version":"4.1.0"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1001\/jamadermatol.2019.0440","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T11:33:41Z","timestamp":1556710421000},"page":"688","source":"Crossref","is-referenced-by-count":117,"title":["Risk of Melanoma Recurrence After Diagnosis of a High-Risk Primary Tumor"],"prefix":"10.1001","volume":"155","author":[{"given":"Lena A.","family":"von Schuckmann","sequence":"first","affiliation":[{"name":"Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia"},{"name":"School of Public Health, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Celia B.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Ghiasvand","sequence":"additional","affiliation":[{"name":"Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryrose","family":"Malt","sequence":"additional","affiliation":[{"name":"Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolieke C.","family":"van der Pols","sequence":"additional","affiliation":[{"name":"School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Beesley","sequence":"additional","affiliation":[{"name":"Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiarash","family":"Khosrotehrani","sequence":"additional","affiliation":[{"name":"Experimental Dermatology Group, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia"},{"name":"Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Mark","family":"Smithers","sequence":"additional","affiliation":[{"name":"Queensland Melanoma Project, Princess Alexandra Hospital, The University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele C.","family":"Green","sequence":"additional","affiliation":[{"name":"Population Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia"},{"name":"Cancer Research UK Manchester, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"doi190016r1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.amepre.2014.08.036","article-title":"Prevalence and costs of skin cancer treatment in the US, 2002-2006 and 2007-2011.","volume":"48","author":"Guy","year":"2015","journal-title":"Am J Prev Med"},{"issue":"6","key":"doi190016r2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031.","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"1","key":"doi190016r3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/bjd.15510","article-title":"The global burden of melanoma: results from the Global Burden of Disease Study 2015.","volume":"177","author":"Karimkhani","year":"2017","journal-title":"Br J Dermatol"},{"issue":"6","key":"doi190016r4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"doi190016r5","first-page":"126","article-title":"Systemic therapy of metastatic melanoma: on the road to cure.","volume":"29","author":"Bhatia","year":"2015","journal-title":"Oncology (Williston Park)"},{"issue":"9","key":"doi190016r6","first-page":"18","article-title":"A global review of melanoma follow-up guidelines.","volume":"6","author":"Trotter","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"issue":"3","key":"doi190016r7","first-page":"231","article-title":"Staging and follow-up of cutaneous melanoma patients.","volume":"152","author":"Guti\u00e9rrez Garc\u00eda-Rodrigo","year":"2017","journal-title":"G Ital Dermatol Venereol"},{"issue":"35","key":"doi190016r8","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1200\/JCO.2010.34.2956","article-title":"Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.","volume":"29","author":"Turner","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"doi190016r9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jso.24013","article-title":"Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia.","volume":"112","author":"Smithers","year":"2015","journal-title":"J Surg Oncol"},{"issue":"36","key":"doi190016r10","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification.","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"35","key":"doi190016r12","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2013.50.1114","article-title":"Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.","volume":"31","author":"Han","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"doi190016r13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/SLA.0b013e3182306c72","article-title":"Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.","volume":"255","author":"Murali","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"doi190016r14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaad.2018.03.023","article-title":"Melanoma staging: varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.","volume":"79","author":"Veier\u00f8d","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"16","key":"doi190016r15","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database.","volume":"29","author":"Thompson","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"doi190016r16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"doi190016r17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jaad.2018.04.017","article-title":"Survival of patients with early invasive melanoma down-staged under the new eighth edition of the American Joint Committee on Cancer staging system.","volume":"80","author":"von Schuckmann","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi190016r18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/archderm.140.1.67","article-title":"Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival.","volume":"140","author":"Tsao","year":"2004","journal-title":"Arch Dermatol"},{"issue":"8","key":"doi190016r19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1470-2045(05)70283-7","article-title":"Follow-up in patients with localised primary cutaneous melanoma.","volume":"6","author":"Francken","year":"2005","journal-title":"Lancet Oncol"},{"issue":"6","key":"doi190016r20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0002-9610(78)90171-X","article-title":"Metastatic pattern of malignant melanoma: a study of 216 autopsy cases.","volume":"135","author":"Patel","year":"1978","journal-title":"Am J Surg"},{"issue":"21","key":"doi190016r21","doi-asserted-by":"publisher","first-page":"5026","DOI":"10.1002\/cncr.v115:21","article-title":"Interobserver reproducibility of histologic parameters of melanoma deposits in sentinel lymph nodes: implications for management of patients with melanoma.","volume":"115","author":"Murali","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"doi190016r22","first-page":"81","article-title":"Malignant melanoma, with emphasis on first relapse cases.","volume":"7","author":"Hafez","year":"2012","journal-title":"Taibah Univ Med Sci"},{"issue":"4","key":"doi190016r23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/(ISSN)1096-9098","article-title":"The natural course of cutaneous melanoma.","volume":"86","author":"Leiter","year":"2004","journal-title":"J Surg Oncol"},{"key":"doi190016r11","volume-title":"Manual for Staging of Cancer\u20141977","author":"American Joint Committee for Cancer","year":"1977"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamadermatology\/article-pdf\/155\/6\/688\/17657663\/jamadermatology_von_schuckmann_2019_oi_190016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T11:11:02Z","timestamp":1560337862000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2019.0440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2019.0440","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,1]]}}}